World Health Assembly: IP Considerations Play Key Role In Final Outcomes 28/05/2013 by Rachel Marusak Hermann and Brittany Ngo for Intellectual Property Watch 1 Comment Wrapping up one day early, the 66th World Health Assembly adopted a range of public health resolutions and decisions, some with key intellectual property implications, including a decision to convene a technical meeting on new public health R&D projects, a compromise on advancing the poor quality medicines mechanism, and resolutions on both neglected tropical diseases and noncommunicable diseases. Importantly, the novel coronavirus situation drew attention to WHO’s progress in pandemic influenza preparedness.
World Health Assembly: As Members Approve Health R&D Decisions, US Says Time To “Put Our Money Where Our Mouth Is” 27/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 3 Comments Heading into the 66th World Health Assembly, the prospect of a global treaty to address the health needs of developing countries seemed unlikely and years away at best. In a surprising turn in this highly political conversation, the US challenged member states to prove that it could work. That process will start sooner rather than later as members gavelled the resolution and agreed to convene a meeting on health R&D demonstration projects in the next few months.
World Health Assembly: Pandemic Flu Framework Clears Committee 27/05/2013 by William New, Intellectual Property Watch 1 Comment Member states gathered at the annual World Health Assembly took note of a report on its pandemic influenza preparedness (PIP) framework amid encouragement by developed countries that standard agreements for transferring materials be completed, and reminders from some developing countries of the need for fair access and benefit-sharing of the resulting treatments.
Focus On Quality For Patients Saves Billions Of Dollars 27/05/2013 by Intellectual Property Watch Leave a Comment Daniela Bagozzi writes: Ten years of efforts in treatment for priority diseases has yielded impressive results both in terms of lives and dollars saved. To maintain progress in a volatile and financially tight environment countries and the international community will need to increase pressure on quality and healthy generic competition.
World Health Assembly: Committee Breaks Deadlock On Poor Quality Meds Mechanism 26/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 3 Comments Breaking six months of deadlock, WHA members reached a compromise in committee on the issue of which country should preside over the global mechanism on poor quality medicines by supporting Brazil’s proposal to rotate the steering committee chairmanship. The Assembly will likely approve the decision.
World Health Assembly: Drafting Group Agrees On Health R&D Meeting Proposal 25/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 1 Comment An informal drafting group finalised a text today, proposing to convene a technical meeting to help identify new health research and development projects for diseases that primarily affect poor communities.
World Health Assembly: Members Debate US Proposed Advisory Meeting On Health R&D 24/05/2013 by Rachel Marusak Hermann, Intellectual Property Watch 1 Comment Taking the World Health Assembly by surprise, the US delegation today made a proposal to advance progress on the monitoring, coordination, and financing of health R&D in committee discussions today. Their suggestion to convene an advisory meeting is being discussed in an informal drafting group in a side room. The committee has adjourned until Monday, but the drafting group will continue over the weekend.
WHO Should Have The Evidence? Ben Goldacre Refutes WHO Director’s Claim 24/05/2013 by Intellectual Property Watch 2 Comments “Bad Science” adversary and journalist, Dr Ben Goldacre, this week challenged WHO Director of Ethics and Social Determinants of Health, Dr Rüdiger Krech, on his understanding of published evidence.
World Health Assembly: Groups Seek To Return Focus To ‘Broken’ Medical R&D System 24/05/2013 by Brittany Ngo for Intellectual Property Watch and William New Leave a Comment The issue of access to medicines is on the agenda at this week’s World Health Assembly (WHA) and public health advocates are seeking greater clarity and detail about the latest member state effort to address failings in the global system of research and development for medical products.
World Health Assembly: Draft Of NCD Action Plan Shows Compromises On IPRs 23/05/2013 by William New, Intellectual Property Watch Leave a Comment Negotiators worked late last night to reach some compromise on the intellectual property-related component of the emerging World Health Organization action plan on noncommunicable diseases.